Top Markets
Coin of the day
Stemcell Holdings, Inc. Stemcell Holdings, Inc.

Stemcell Holdings, Inc.

STMM
株式のランク #37518
Stemcell Holdings, Inc., primarily operating through its subsidiary Stemcell... Stemcell Holdings, Inc., primarily operating through its subsidiary Stemcell Co., Ltd., specializes in the regenerative medicine sector. The company provides crucial technical support for the cultivation, storage, and delivery of stem cells, alongside administrative and consulting services for clinics. It offers two distinct stem cell regenerative therapies: autologous mesenchymal stem cells derived from adipose tissue and natural killer cells. To facilitate its stem cell culturing activities, Stemcell Holdings coordinates patient introductions to clinics, manages scheduling, and provides translation services to overcome language barriers between patients and medical professionals. Additionally, the firm offers internet marketing solutions, specifically search engine optimization for clinics, and engages in property and equipment rental. Founded in Tokyo, Japan, in 2015, the company was formerly known as Perfect Acquisition, Inc. before changing its name to Stemcell Holdings, Inc. in January 2016. As of May 2, 2016, Stemcell Holdings, Inc. operates as a subsidiary of Primavera Singa Pte Ltd.
株価
$0.06
最終同期: 2026-04-08
時価総額
$1.64M
変化(1日)
0.00%
変化(1年)
0.00%
JP
取引 Stemcell Holdings, Inc. (STMM)

カテゴリー

Stemcell Holdings, Inc.(STMM)の営業利益率
2026 時点の営業利益率 TTM: 0.00%
Stemcell Holdings, Inc. の最新の財務報告と株価によると、現在の営業利益率(TTM)は 0.00% です。2026 年末時点では 0.00% でした。
Stemcell Holdings, Inc. の営業利益率の履歴(2026 から 2026)
各年末の営業利益率
営業利益率 変化
提供された日付のデータは十分ではありません。
同業他社の営業利益率
企業 営業利益率 営業利益率の差
38.97% -
US
28.81% -
NL
0.00% -
CH
0.00% -
KR
31.23% -
BE
企業の営業利益率とは?
営業利益率は、企業の収益性を評価するための重要な指標です。高い営業利益率は一般的に良いとされており、企業が製品やサービスをその生産コストよりもはるかに高く販売できていることを示します。営業利益率は、企業の利益を売上高で割ることで計算されます。